JP2009524829A - ヒトｉｖｆ由来胚のプロテオームフィンガープリンティング：発生能のバイオマーカーの同定法 - Google Patents

ヒトｉｖｆ由来胚のプロテオームフィンガープリンティング：発生能のバイオマーカーの同定法 Download PDF

Info

Publication number
JP2009524829A
JP2009524829A JP2008552490A JP2008552490A JP2009524829A JP 2009524829 A JP2009524829 A JP 2009524829A JP 2008552490 A JP2008552490 A JP 2008552490A JP 2008552490 A JP2008552490 A JP 2008552490A JP 2009524829 A JP2009524829 A JP 2009524829A
Authority
JP
Japan
Prior art keywords
biomarker
biomarkers
adsorbent
ivf
embryo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008552490A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009524829A5 (OSRAM
Inventor
セルジオ シー． オーニンガー
オー． ジョン セムズ
リサ エイチ． カザレス
シルビナ ボッカ
Original Assignee
イースタン バージニア メディカル スクール
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イースタン バージニア メディカル スクール filed Critical イースタン バージニア メディカル スクール
Publication of JP2009524829A publication Critical patent/JP2009524829A/ja
Publication of JP2009524829A5 publication Critical patent/JP2009524829A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2008552490A 2006-01-27 2007-01-29 ヒトｉｖｆ由来胚のプロテオームフィンガープリンティング：発生能のバイオマーカーの同定法 Pending JP2009524829A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76249206P 2006-01-27 2006-01-27
PCT/US2007/002456 WO2007089734A2 (en) 2006-01-27 2007-01-29 Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential

Publications (2)

Publication Number Publication Date
JP2009524829A true JP2009524829A (ja) 2009-07-02
JP2009524829A5 JP2009524829A5 (OSRAM) 2010-03-25

Family

ID=38327982

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008552490A Pending JP2009524829A (ja) 2006-01-27 2007-01-29 ヒトｉｖｆ由来胚のプロテオームフィンガープリンティング：発生能のバイオマーカーの同定法

Country Status (6)

Country Link
US (1) US20090215085A1 (OSRAM)
EP (1) EP1994408A4 (OSRAM)
JP (1) JP2009524829A (OSRAM)
AU (1) AU2007209980A1 (OSRAM)
CA (1) CA2640614A1 (OSRAM)
WO (1) WO2007089734A2 (OSRAM)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017535750A (ja) * 2014-09-24 2017-11-30 マップ アイピー ホールディング リミテッド 妊娠の予後を提供する方法
JP2019170235A (ja) * 2018-03-28 2019-10-10 国立大学法人 大分大学 胚の評価方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889127B2 (en) 2004-07-01 2014-11-18 Icahn School Of Medicine At Mount Sinai Targeted protein replacement for the treatment of lysosomal storage disorders
WO2009032288A1 (en) * 2007-09-07 2009-03-12 New York University School Of Medicine Methods for predicting embryo viability
WO2009075862A1 (en) * 2007-12-11 2009-06-18 New York University School Of Medicine Method of assessing viability of embryos in vitro
SI2753346T1 (sl) 2011-09-07 2020-09-30 Mount Sinai School Of Medicine Ceramidaza in diferenciacija celic
RU2474823C1 (ru) * 2011-09-26 2013-02-10 Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования качества эмбрионов в программе экстракорпорального оплодотворения
LT2854910T (lt) 2012-06-01 2020-05-25 Icahn School Of Medicine At Mount Sinai Ceramido lygiai infekcijos gydymo ir prevencijos metu
HUE046113T2 (hu) 2013-03-14 2020-02-28 Icahn School Med Mount Sinai Terápiás sav ceramidáz készítmények és azok elõállítási és felhasználási eljárásai
CN111279421B (zh) * 2017-09-29 2024-04-09 布里格姆妇女医院 人类胚胎的自动评价
RU2706683C1 (ru) * 2019-06-05 2019-11-20 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ прогнозирования готовности эндометрия к успешной имплантации эмбриона у женщин с маточной формой бесплодия с использованием компьютерной морфометрии
WO2021016581A1 (en) 2019-07-25 2021-01-28 Overture Life, Inc. Identification of viable human embryos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462454B (sv) * 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
US6283761B1 (en) * 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
ATE242485T1 (de) * 1993-05-28 2003-06-15 Baylor College Medicine Verfahren und massenspektrometer zur desorption und ionisierung von analyten
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US5994148A (en) * 1997-06-23 1999-11-30 The Regents Of University Of California Method of predicting and enhancing success of IVF/ET pregnancy
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
WO2000067293A1 (en) * 1999-04-29 2000-11-09 Ciphergen Biosystems, Inc. Sample holder with hydrophobic coating for gas phase mass spectrometers
DE60025022D1 (de) * 1999-09-27 2006-01-26 Clifford L Librach Nachweis von hla-g
EP1386275A2 (en) * 2000-07-18 2004-02-04 Correlogic Systems, Inc. A process for discriminating between biological states based on hidden patterns from biological data
US7113896B2 (en) * 2001-05-11 2006-09-26 Zhen Zhang System and methods for processing biological expression data
JP4264002B2 (ja) * 2001-07-17 2009-05-13 バイオ−ラド ラボラトリーズ インコーポレイテッド ラテックスベース吸着チップ
US20020193950A1 (en) * 2002-02-25 2002-12-19 Gavin Edward J. Method for analyzing mass spectra
US20030218130A1 (en) * 2002-05-02 2003-11-27 Ciphergen Biosystems, Inc. Biochips with surfaces coated with polysaccharide-based hydrogels
ATE426808T1 (de) * 2002-07-24 2009-04-15 Bio Rad Laboratories Proteininteraktionsdifferenzabbildung
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US7572601B2 (en) * 2004-10-15 2009-08-11 Northwestern University Compositions and methods for determining oocyte development potential

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017535750A (ja) * 2014-09-24 2017-11-30 マップ アイピー ホールディング リミテッド 妊娠の予後を提供する方法
JP2019170235A (ja) * 2018-03-28 2019-10-10 国立大学法人 大分大学 胚の評価方法
JP7134462B2 (ja) 2018-03-28 2022-09-12 国立大学法人 大分大学 胚の評価方法

Also Published As

Publication number Publication date
AU2007209980A1 (en) 2007-08-09
US20090215085A1 (en) 2009-08-27
EP1994408A4 (en) 2009-05-06
WO2007089734A2 (en) 2007-08-09
WO2007089734A3 (en) 2008-07-24
CA2640614A1 (en) 2007-08-09
EP1994408A2 (en) 2008-11-26

Similar Documents

Publication Publication Date Title
JP2009524829A (ja) ヒトｉｖｆ由来胚のプロテオームフィンガープリンティング：発生能のバイオマーカーの同定法
US12339288B2 (en) Multi-protein biomarker assay for brain injury detection and outcome
JP5011410B2 (ja) 生体液のプロテオーム分析
US20090042229A1 (en) Platelet biomarkers for cancer
JP2006524331A5 (OSRAM)
EP2118664A1 (en) Peptide markers for diagnosis of preeclampsia
US8440409B2 (en) Protein C inhibitor as a biomarker for prostate cancer
US8221984B2 (en) Biomarkers for ovarian cancer
JP2023518280A (ja) 改善された特異性及び感度を有する、卵巣がん評価のための組成物
US20090305259A1 (en) Early Diagnosis of Congenital Abnormalities in the Offspring of Diabetic Mothers
US20140147874A1 (en) Biomarkers of cardiac ischemia
CN117677715B (zh) 一种骨髓瘤生物标志物serpinf2及其应用
CN116148482A (zh) 用于乳腺癌患者鉴定的设备及其制备用途
WO2023087004A2 (en) Methods of preparing and analyzing samples for biomarkers associated with placenta accreta
CN117858965A (zh) 一种骨髓瘤生物标志物lgals3bp及其应用
WO2006071843A2 (en) Biomarkers for breast cancer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100127

A072 Dismissal of procedure [no reply to invitation to correct request for examination]

Free format text: JAPANESE INTERMEDIATE CODE: A073

Effective date: 20110616